Wall Street Analysts See a 29.28% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High?

Shares of Amylyx Pharmaceuticals, Inc. (AMLX) have gained 3.6% over the past four weeks to close the last trading session at $14.31, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18.5 indicates a potential upside of 29.3%.The mean estimate comprises eight short-term price targets with a standard deviation of $3.85. While the lowest estimate of $12.00 indicates a 16.1% decline ...